Source: Eur Respir J 2016; 47: 978-980
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bartoli Maria Laura, Costa Francesco, Malagrinò Laura, Nieri Dario, Antonelli Sandra, Decusatis Giovanna, Simone Claudia De, Santerini Sabrina, Cianchetti Silvana, Latorre Manuela, Vagaggini Barbara, Paggiaro Pierluigi. Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines. Eur Respir J 2016; 47: 978-980

Member's Comments

No comment yet.

Related content which might interest you: Monitoring COPD patients according to the GOLD 2017 document: systemic and bronchial inflammation. Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011 Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 2011 GOLD categories may identify different copd phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations? Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework Source: Annual Congress 2012 - COPD epidemiology Year: 2012 GOLD recommendations for COPD management Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019 Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004